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GFP–Vpr labeled HIV-1 virions have provided a method to visually examine the interactions between the virus and target cell during infection.
However, existing methods to discriminate between virions that have been non-specifically endocytosed from those that have productively entered
the host cell cytoplasm have remained problematic. Therefore, we examined the ability of a series of membrane-targeted fluorescent fusion protein
constructs to be incorporated into virions. We find that a fluorescent protein fusion targeted to the plasma membrane by the addition of the N-
terminal 15 amino acid sequence of c-Src (S15) is efficiently packaged into HIV virions. Using fluorescent proteins fused to this sequence, we
have generated virions dually labeled with S15–mCherry and GFP–Vpr. Importantly, we can detect the loss of this S15–mCherry membrane
signal following fusion.
After infection with VSV-g pseudotyped HIV virions, we find a measurable, specific loss of membrane label during infection. This loss of
fluorescence is not observed when fusion is prevented using bafilomycin A. This increased ability to discriminate between non-productively
endocytosed virions and those actively undergoing steps in the infectious process will facilitate efforts to examine early steps in infection
microscopically.
© 2006 Elsevier Inc. All rights reserved.Keywords: Fusion; Microscopy; Infection; Endocytosis; mCherry; SrcIntroduction
Infection of a host cell by HIV-1 requires fusion of the viral
membrane with the membrane of the host cell, thereby releasing
the viral core into the host cell cytoplasm. Once in the cytoplasm,
the viral core undergoes a series of trafficking and replicative
events required to establish infection. To access nuclear host cell
DNA, the HIV-1 core must be directionally trafficked towards
the nucleus. During this time, the virus undergoes the poorly
understood process of uncoating, which is the sequential loss of
viral proteins from the preintegration complex (PIC) containing
the viral genome. During this time, the viral RNA genome is
converted to DNA, and this DNA is ultimately imported into the
nucleus of the target cell and integrated into the host cell⁎ Corresponding author. Fax: +1 312 503 2696.
E-mail address: thope@northwestern.edu (T.J. Hope).
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0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2006.10.025chromosome (reviewed in Dvorin and Malim, 2003). However,
studies examining these events have lagged behind other areas of
HIV research such as viral fusion, gene regulation and virus
production because the latter have been more easily studied
using classical biochemical and molecular biology approaches.
In recent years fluorescent microscopy has become an invaluable
tool to examine the intracellular trafficking and early replicative
events of viruses during infection (reviewed in Campbell and
Hope, 2005; Dohner et al., 2005). However, it has been shown
that, in the case of HIV-1, nonspecific receptor-independent
uptake of HIV virions occurs at high frequency (Marechal et al.,
1998; McDonald et al., 2002; Schaeffer et al., 2001). Therefore,
analysis of the intracellular trafficking of enveloped virions
requires the ability to discriminate between virions that have
fused with the host cell membrane from virions that have
nonproductively entered the host cell via endocytosis.
Our lab has previously examined the intracellular behavior
of HIV by fluorescently labeling the HIV core with a GFP–Vpr
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fluorescent, membrane intercalating dye DiD (McDonald et al.,
2002). However, the efficiency of DiD labeling of virus can
vary considerably between different viral preparations. We
therefore sought to develop another method to label the
membrane of virions with increased specificity and consistency.
To this end, we examined the incorporation of a series of GFP
fusion proteins targeted to the plasma membrane or otherwise
known to be incorporated into HIV virions. We find a
fluorescent fusion protein containing the 15 N-terminal amino
acids of Src (Rodgers, 2002) is efficiently incorporated into
HIV virions and is lost following fusion of the viral membrane
with the host cell membrane, thus providing a powerful tool to
identify fluorescently labeled HIV virions that have produc-
tively entered the host cell.
Results
Incorporation of fluorescent fusion proteins into HIV virions
We first wanted to examine the ability of specific GFP-fusion
proteins to be incorporated into HIV virions. A series of fusion
proteins were chosen for their ability to associate with the host
cell plasma membrane or for their ability to otherwise be
incorporated into HIV virions. These fusion proteins were then
coexpressed in virus-producing 293T cells also expressing an
mRFP–Vpr fusion protein to label HIV-1 cores. Specifically,
the membrane associated proteins examined were GFP
derivatives containing the farnesylation sequence of p21(Ras)
(EGFP-F) (Harvey et al., 2001), another containing the 10 N-
terminal, membrane targeting amino acids of the Src tyrosine
kinase p56lck fused to GFP (L10–GFP) (Rodgers, 2002;
Rodgers et al., 1994; Shenoy-Scaria et al., 1993), and one
containing the 15 N-terminal membrane targeting amino acids
of p60c-Src fused to GFP (S15–GFP) (Rodgers, 2002; Shenoy-
Scaria et al., 1993). GFP fusions to the viral accessory protein
Nef (Nef–GFP) and the cellular protein Cyclophilin A (CypA–
GFP) were also examined since each has been reported to be
specifically incorporated into HIV virions (Bukovsky et al.,
1997; Franke et al., 1994; Thali et al., 1994; Welker et al.,
1998). A GFP fusion targeted to the outer membrane of cells via
a glycosyl–phosphatidyl–inositol (GPI) anchor was also
examined but strongly inhibited virus production, and was
therefore not studied further (data not shown). Unfused GFP
was included as a control to determine the specificity of the
virion incorporated fluorescence observed in these experiments.
Virus collected from cells expressing the above GFP fusions
was bound to glass coverslips, stained for p24 and imaged.
mRFP–Vpr signal was observed to overlap with p24 staining,
revealing that mRFP–Vpr is incorporated into virions (Fig. 1B).
When the GFP fluorescent intensity of mRFP–Vpr+, p24+
HIV-1 virions was examined, minimal incorporation of L10–
GFP and CypA–GFP was detected. However, measurable
incorporation of Nef–GFP, EGFP-F and S15–GFP into HIV
virions was observed. Of these three proteins, S15–GFP
incorporation was highest in terms of average virion fluores-
cence (Fig. 1A) and the percentage of virions labeled (Fig. 1B).Similar results were obtained when the S15 leader sequence was
attached to the recently developed red fluorescent protein
mCherry (Shaner et al., 2004) and virion cores were labeled
with the better characterized GFP–Vpr protein (McDonald et
al., 2002) (Fig. 1C). Virion labeling with either S15–GFP or
S15–mCherry typically resulted in detectable fluorescence in
greater than 90% of virions as determined by p24 staining. By
contrast, labeling with GFP–Vpr or mRFP–Vpr typically
generated detectable fluorescence in 40–80% of virions as
determined by p24 staining under these conditions (data not
shown). In the absence of HIV transfection, supernatants from
S15–mCherry transfected 293T cells did not release appreciable
amounts of labeled membrane into the supernatant when these
supernatants were exposed to glass coverslips as in Figs. 1B, C
(data not shown). S15 expression in the virus-producing 293T
cells did not negatively affect virus production (data not
shown). Moreover, when equivalent amounts of a GFP reporter
virus were used to infect HeLa cells, virus preparations labeled
with GFP–Vpr, S15–mCherry or both proteins remained as
infectious as unlabeled VSV-g pseudotyped virus (Fig. 1D).
S15–mCherry localizes to areas of microvilli and cell
projection
We next sought to examine the intracellular localization of
S15–mCherry in transfected cells. S15–mCherry expressing
293Tcells were fixed and stained for ezrin. Ezrin is a member of
the ezrin radixin moesin family of protein that links the actin
cytoskeleton to the plasma membrane (Bretscher et al., 2002).
Our lab has found that ezrin is present on microvilli and other
cell protrusions where CD4 and CCR5 accumulate (Steffens
and Hope, 2003) as do constructs expressing HIV matrix and
matrix–capsid fused to GFP (Gomez and Hope, 2006). As
expected, S15–mCherry was observed to localize primarily to
the plasma membrane, accumulating in ezrin containing
structures in 293T cells (Fig. 2), while a small amount localized
to discreet intracellular vesicular compartments.
Loss of S15–mCherry from HIV virions correlates with fusion
with target cells
Since S15–mCherry was able to label virion membranes with
high efficiency (Fig. 1), we next sought to determine if the
S15–mCherry signal was lost from GFP–Vpr labeled virions
upon fusion with target cells. We therefore infected HeLa cells
with VSV-g pseudotyped HIV virions dually labeled with
S15–mCherry and GFP–Vpr. We chose VSV-g envelope
because it fuses with target cells at high efficiency and can be
effectively inhibited by drugs such as bafilomycinA1 (BafA) that
inhibit endosome acidification (Bowman et al., 1988; Yoshimori
et al., 1991). To synchronize entry of virus into target cells, HeLa
cells were spinoculated at 17 °C to allow virion binding but
prevent virion endocytosis (O'Doherty et al., 2000). Following
spinoculation, cells were transferred to 37 °C in the presence or
absence of BafA. These cells were then fixed at various times
post-spinoculation and imaged. In cells pretreated with bafilo-
mycin A (BafA), which prevents fusion of VSV-g pseudotyped
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Fig. 2. S15–mCherry localizes to dynamic areas of the plasma membrane in 293T cells. 293T cells in a 6-well plate were transfected with 3 μg S15–mCherry using
PEI. 24 h posttransfection, cells were stained with a monoclonal antibody specific for ezrin and analyzed by fluorescent microscopy. Insert: Membrane areas containing
S15–GFP also stained positively for ezrin.
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mCherry 2 h post infection (PI) (Fig. 3A). In the absence of drug,
however, while some S15–mCherry labeled virions were still
clearly visible 2 h post infection, a population of GFP–Vpr+
virions that lacked S15–mCherry labeling had emerged
(Fig. 3B). We conclude that productive entry into target cells
results in the loss of S15–mCherry signal from HIV-1 virions.
Kinetic analysis of HIV-1 infection of target cells using
S15–mCherry
The ability to discriminate between virions that have
productively entered the target cell from those that have not
allowed us to examine the fate of both of these viral populations
over time. When infection was mediated by spinoculation at
17 °C, cells fixed immediately after spinoculation maintained
their S15–mCherry signal in the presence or absence of BafA
(Fig. 4A). The viral supernatant was removed from the
remaining coverslips, replaced with fresh media and tempera-
ture was shifted to 37 °C. When these cells were fixed 1–4 h PI,
the overall number of GFP–Vpr+ virions was observed to
decrease over time. In contrast there was no decrease in the
number of GFP–Vpr labeled particles after 4 h in the presence
of BafA (Fig. 4A). BafA treatment prevented both the reduction
of virion number and loss of S15–mCherry labeling (Fig. 4A),
suggesting that endosomal acidification is required both for
fusion of VSV-g pseudotyped virions and degradation of virions
which do not achieve productive entry to the target cell. After
1 h of incubation at 37 °C the total number of GFP–Vpr positive
particles decreased by approximately 50%. Analysis of
associated S15–mCherry signal at the 1 h time point revealedFig. 1. Incorporation of fluorescent fusion proteins into HIV-1 virions. (A) mRFP–
construct were filtered through a 0.45-μm filter and bound to glass coverslips for 4
mRFP–Vpr positive virions was quantified using the data inspector function of Ap
measured in 20 or more mRFP–Vpr+ virions. Fusions containing the 15 N-terminal
S15–GFP (B) or S15–mCherry (C) was used. (D) HeLa cells were infected with 40
with the indicated fluorescent proteins. GFP expression was measured 48 h later bya decrease in the number of S15–mCherry+ virions. This was
mirrored by an increase in the number of virions lacking
S15–mCherry signal representing viral cores that had entered
the cytoplasm (Figs. 4A, B). Following this increase in the
number of cytoplasmic virions observed at 1 h PI, this viral
population remained largely intact 2 h PI and was then observed
to decline by 4 h PI (Figs. 4A, B). The unfused, S15–mCherry+
population, however, was observed to steadily decline between
1 and 4 h PI, so that by 4 h, the vast majority of cellular virions
had lost their S15–mCherry membrane label (Figs. 4A, B). The
analysis of the ratio of the S15–mCherry labeled GFP–Vpr
signal to those that had lost their membrane label in the
remaining viral population is shown in the insert in Fig. 4B.
This analysis reveals that initially, less than 5% of the virions
were S15–mCherry negative. In contrast after 4 h the S15–
mCherry negative virions represented more than 80% of the
remaining GFP–Vpr labeled population. Similarly, when HIV-1
virions lacking envelope were used to infect target cells, the
S15–mCherry signal was not lost. However, in this case, the
number of virions was observed to decrease over time (data not
shown). We conclude that the loss of S15–mCherry signal from
GFP–Vpr labeled virions correlates with the ability of virions to
fuse with target cells and therefore identifies virions that have
productively entered the target cell.
Discussion
In this study, we find that the attachment of the 15 N-terminal
amino acids of c-Src can drive incorporation of fluorescent
fusion proteins into budding HIV virions. Targeting GFP to the
plasma membrane by other sequences had limited ability toVpr labeled virions produced from 293T cells cotransfected with the indicated
h, fixed and immunostained with mAb specific for p24CA. GFP fluorescence of
plied Precision software. Error bars represent the SEM of the GFP intensities
amino acids of c-Src were found to efficiently label HIV-1 virions whether an
ng VSV-g pseudotyped GFP reporter virus lacking fluorescent label or labeled
flow cytometry.
Fig. 3. Virion incorporated S15–mCherry signal is lost following productive
entry into target cells. HeLa cells were spinoculated (O'Doherty et al., 2000)
with VSV-g pseudotyped, S15–mCherry and GFP–Vpr labeled R7ΔEnv virions
for 2 h at 17 °C. Virus was removed and replaced with 37 °C media and then
additionally incubated for 2 h at 37 °C in the presence (A) or absence (B) of
BafA. Cells were then fixed, stained for DNA and imaged. Arrows indicate
virions that do not have detectable S15–mCherry labeling.
Fig. 4. Temporal analysis of S15–mCherry loss following infection. HeLa cells
were spinoculated with VSV-g pseudotyped, S15–mCherry GFP–Vpr labeled
R7ΔEnv virions for 2 h at 17 °C. Virus was removed and replaced with 37 °C
media. Cells were incubated at 37 °C, fixed at the indicated time PI and imaged.
GFP positive puncta were than quantified and individually examined for the
presence of above background mCherry signal. (A) Representative experiment
in which the number of virions observed per 10 Z-stack fields was calculated at
the indicated time points in the presence or absence of BafA. Grey bars indicate
the number of S15–mCherry positive virions and black bars indicate the number
of S15–mCherry negative virions. Numbers above each time point indicate the
percentage of GFP–Vpr positive virions lacking S15–mCherry signal. (B) Total
number of virions compiled from pooled data derived from 3 independent
experiments. The input virion level was normalized to 100% in order to
accommodate differences in initial observed viral input. The changes in the
populations of total virions (♦) S15–mCherry positive virions (▪) and S15–
mCherry negative ( ) virions over time is shown. (Panel B inset) The relative
amount of S15–mCherry positive virions (▪) and S15–mCherry negative (▴)
virions as a percentage of the remaining viral population. Error bars represent the
standard error of the mean of three experiments.
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specific membrane regions targeted by S15 fusion constructs is
necessary for virion incorporation. This stretch of amino acids
contains a myristoylated Gly2 residue followed by a string of
basic amino acids known to be responsible for the membrane
association of c-Src (reviewed in Resh, 1994). It has been
shown that association of Nef with the plasma membrane and
subsequent incorporation into HIV virions depends on a similar
stretch of basic residues flanking a myristoylated glycine
(Welker et al., 1998). It was therefore not surprising that both of
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HIV virions to similar degrees (Fig. 1A). However, it has been
reported that the S15–GFP protein is associated exclusively
with the detergent soluble membrane (DSM) fraction (Rodgers,
2002). Alternatively, it has been reported that the HIV structural
precursor protein Pr55Gag localizes initially to the DS fraction
but subsequently localizes to the detergent-resistant membrane
(DRM) fraction containing glycolipid enriched membrane, or
lipid rafts, prior to virion release (Ono and Freed, 2001).
Despite this minor discrepancy, our microscopic analysis
indicates that S15–mCherry localizes to ezrin containing
membrane structures (Fig. 2), in which Gag–GFP is also
known to accumulate during assembly (Gomez and Hope,
2006), demonstrating that the S15 sequence directs proteins to
the area of the plasma membrane that supports viral assembly.
To date, the preferred method to induce incorporation of non-
viral proteins into HIV virions has been the generation of fusion
proteins tethered to the viral Vpr protein (Cavrois et al., 2002;
McDonald et al., 2002; Sato et al., 1995; Wu et al., 1995). The
attachment of the S15 leader sequence onto non-viral proteins
similarly provides an alternative mechanism to drive virion
incorporation. In fact, this method may prove to be more
effective than Vpr fusions. In these experiments, membrane
labeling directed by the S15 sequence always labeled a higher
percentage of virions than was observed by the Vpr fusion
protein, regardless of the combination of fluorescent proteins
used (data not shown). This is likely because high levels of Vpr
expression in virus-producing cells can negatively affect virus
production (data not shown). Therefore, inducing virion
incorporation of non-virion proteins by generation of fusion
proteins containing the S15 sequence may prove more effective
than Vpr in some cases, especially when there is no need for the
protein to remain associated with the HIV preintegration
complex following fusion. Such a mechanism for driving virion
incorporation of non-virion proteins by inducing their mem-
brane association may likely be achievable using other
membrane targeting sequences and is likely not specific to
HIV. Others have observed that GFP incorporation into virions
can be achieved by tethering GFP to the membrane targeting
sequence of HIV-1 Nef (Welker et al., 1998), consistent with the
results observed in Fig. 1A. Moreover, a palmitylated form of
yellow fluorescent protein (YFP) has been shown to be
efficiently incorporated into murine leukemia virus (Melikyan
et al., 2005). In this regard, fluorescent proteins targeted to
different sites in the membrane may therefore provide insight
into the specific membrane microdomains used as assembly
platforms by different viruses.
The ability of dually labeled virions to serve as a marker for
viral fusion represents a significant step in our ability to track
the interactions of the viral preintegration complex with the host
cell. S15–mCherry signal is retained when virion fusion is
prevented with BafA, which inhibits fusion mediated by pH
dependent envelopes such as VSV-g, and following endocytosis
of HIV-1 virions lacking an envelope protein, demonstrating
that loss of S15 associated membrane signal occurs only when
fusion occurs. Using this system to monitor fused and unfused
viral populations over time following synchronized infection,we observed the disappearance of detectable cellular virions.
Most of this loss occurs rapidly and represents the loss of the
S15–mCherry positive viral population in the first hour post
infection. This loss cannot completely be accounted for by
conversion of this population to a cytoplasmic S15–mCherry
negative population, but can be prevented with BafA. This
suggests that many virions are rapidly degraded following
endocytosis before they can enter the target cell, even when
virions are pseudotyped with VSV-g.
Further work is required to determine the fate of GFP–Vpr
labeled virions following fusion. By 4 h PI, we observed a
significant reduction in the number of cytoplasmic virions
compared to earlier time points. Three factors could be
contributing to the loss of cytoplasmic GFP–Vpr labeled
cores that we observed over time in these experiments. Most
obviously, the loss of GFP–Vpr signal could represent the fact
that the viral DNA has been imported into the nucleus. This
would include the loss of GFP–Vpr association from the PIC, as
we do not observe GFP–Vpr positive punctate in the nucleus of
target cells (data not shown). This is consistent with other work,
which has measured nuclear viral DNA as early as 3 h following
an unsynchronized infection (Bukrinsky et al., 1992). Second,
there may be a proteasome-dependent mechanism by which
cytoplasmic virions are degraded. This is consistent with
previous reports showing an antiviral activity of the proteasome
in HIV-1 infection (Schwartz et al., 1998), as well as our own
data showing that proteasome inhibition does increase the
stability of GFP–Vpr labeled virions over time (data not
shown). Third, GFP–Vpr association with the viral PIC may be
lost or become reduced during the process of uncoating and
cDNA generation. Lastly, the loss of fluorescent signal we
measured may be a result of pH quenching of fluorescent
proteins within the lysosomal compartment. Such quenching
has been reported previously, although it was also found that
this quenching was rapidly reversible upon return to neutral pH
(Melikyan et al., 2005). This effect would result in an
underestimation of the number of unfused virions, although
these virions would be subjected to conditions that would
rapidly lead to their degradation in the absence of VSV-g
mediated fusion. More work is required to understand how
much each of these components contributes to the loss of GFP–
Vpr labeled virions we observed in these experiments. The
ability to discriminate between virions that have fused with the
target cell, combined with the ability to synchronize infection
by spinoculation, will allow these issues to be examined in more
detail. Moreover, these methods will also facilitate the direct
observation of early events during infection, as well as allow
analysis of the protein composition of the viral preintegration
complex, which should lead to an in situ characterization of the
still poorly understood process of uncoating.
Materials and methods
Cells and pharmaceuticals
293T and HeLa cells (American Type Culture Collection)
were cultured at 37 °C, 7% CO2 in Dulbecco's modified
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100 U/ml penicillin, 100 μg/ml streptomycin, 292 μg/ml
L-glutamine and 10 μg/ml ciprofloxacin. Bafilomycin A1
(Sigma) was prepared in DMSO and diluted to a final
concentration of 20 nm in DMEM.
Virus and infections
To screen virion incorporation of fusion proteins, 293T cells
in 6-well plates were transfected with 1.75 μg of the indicated
fusion protein expression plasmid was cotransfected with
1.75 μg R7Δenv GFP, 1 μg VSV-g and 0.1 μg mRFP–Vpr
using polyethylenimine (PEI) (MW 25,000, Polysciences). To
generate virus uses in infection, 10-cm plates of 293T cells were
transfected with 7.4 μg R7Δenv GFP, 4.2 μg VSV-g, 0.5 μg
GFP–Vpr, and 6.4 μg S15–mCherry using PEI. Virus was
harvested 48 h post-transfection. To synchronize infection,
target cells were seeded on fibronectin treated coverslips and
spinoculated (O'Doherty et al., 2000) with 0.5 ml of virus at a
concentration of 50–300 ng/ml for 2 h at 17 °C in the presence
or absence of the indicated drug. Virus was then removed and
replaced with 37° media in the presence or absence of the
indicated drug and fixed at the indicated time point post
infection. In Fig. 1D, the viral inoculum was replaced with fresh
media 14 h PI and GFP expression was measured 48 h later
using a FACS Calibur flow cytometer analyzing 5000 events
per infection (Becton Dickinson).
Immunofluorescence and microscopy
Virions or cells on glass coverslips were fixed with 3.7%
formaldehyde (Polysciences) in 0.1 M Pipes buffer, pH 6.8.
Coverslips were stained with α-p24 mAb AG3.0 (NIH AIDS
Research and Reference Reagent Program) or α-ezrin (Cytos-
keleton Inc.) in blocking solution (10% normal donkey serum
(Jackson ImmunoResearch Laboratories), 0.1% Triton X-100,
0.01% NaN3) for 1 h at RT for primary stain and secondarily
stained with labeled (AMCA, Cy5) donkey anti-mouse
antibodies (Jackson ImmunoResearch Laboratories). Coverslips
were mounted with Gel Mount (Biomedia). Images were
collected and deconvolved with a Deltavision microscope and
software (Applied Precision).
Statistical image analysis
Following deconvolution, the number of GFP positive
virions was assessed and each virion was individually inspected
for punctate mCherry fluorescent signal. Between 9 and 25
images were analyzed for each data point provided. During
analysis, channel intensity was increased above the level of the
included figures to detect low level fluorescence.
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